Kinaset Advances Inhaled Pan-JAK Inhibitor For Broad Use In Severe Asthma

 
• By Ayisha Sharma
  
Emerging Company Profile: Kinaset Therapeutics
Severe Asthma Patients Can Experience Exacerbations • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Emerging Company Profiles

More from Start-Ups & SMEs